Atlas Trials

[11C]-(R)-Rolipram to Measure cAMP Signaling Before and After Ketamine

Clinical trial NCT05522673 · TERMINATED

Trial details

NCT number
NCT05522673
Sponsor
National Institute of Mental Health (NIMH)
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Depression
Start date
2023-02-08
Primary completion
2023-02-08
Enrollment
1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.